Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like No deadline for introduction of Sharia banking in India: RBI April 9, 2017 India’s Internet landscape June 2, 2017 Isel USA announces AT series of industrial workbenches with T Slot table tops August 19, 2019